Literature DB >> 27348317

Defining a Patient Population With Cirrhosis: An Automated Algorithm With Natural Language Processing.

Edward K Chang1, Christine Y Yu, Robin Clarke, Andrew Hackbarth, Timothy Sanders, Eric Esrailian, Daniel W Hommes, Bruce A Runyon.   

Abstract

OBJECTIVES: The objective of this study was to use natural language processing (NLP) as a supplement to International Classification of Diseases, Ninth Revision (ICD-9) and laboratory values in an automated algorithm to better define and risk-stratify patients with cirrhosis.
BACKGROUND: Identification of patients with cirrhosis by manual data collection is time-intensive and laborious, whereas using ICD-9 codes can be inaccurate. NLP, a novel computerized approach to analyzing electronic free text, has been used to automatically identify patient cohorts with gastrointestinal pathologies such as inflammatory bowel disease. This methodology has not yet been used in cirrhosis. STUDY
DESIGN: This retrospective cohort study was conducted at the University of California, Los Angeles Health, an academic medical center. A total of 5343 University of California, Los Angeles primary care patients with ICD-9 codes for chronic liver disease were identified during March 2013 to January 2015. An algorithm incorporating NLP of radiology reports, ICD-9 codes, and laboratory data determined whether these patients had cirrhosis. Of the 5343 patients, 168 patient charts were manually reviewed at random as a gold standard comparison. Positive predictive value (PPV), negative predictive value (NPV), sensitivity, and specificity of the algorithm and each of its steps were calculated.
RESULTS: The algorithm's PPV, NPV, sensitivity, and specificity were 91.78%, 96.84%, 95.71%, and 93.88%, respectively. The NLP portion was the most important component of the algorithm with PPV, NPV, sensitivity, and specificity of 98.44%, 93.27%, 90.00%, and 98.98%, respectively.
CONCLUSIONS: NLP is a powerful tool that can be combined with administrative and laboratory data to identify patients with cirrhosis within a population.

Entities:  

Mesh:

Year:  2016        PMID: 27348317     DOI: 10.1097/MCG.0000000000000583

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  19 in total

Review 1.  Making Sense of Big Textual Data for Health Care: Findings from the Section on Clinical Natural Language Processing.

Authors:  A Névéol; P Zweigenbaum
Journal:  Yearb Med Inform       Date:  2017-09-11

2.  Liver-related mortality is similar among men and women with cirrhosis.

Authors:  Nikhilesh R Mazumder; Stela Celaj; Kofi Atiemo; Amna Daud; Kathryn L Jackson; Abel Kho; Josh Levitsky; Daniela P Ladner
Journal:  J Hepatol       Date:  2020-04-25       Impact factor: 25.083

3.  Validation of an alcohol misuse classifier in hospitalized patients.

Authors:  Daniel To; Brihat Sharma; Niranjan Karnik; Cara Joyce; Dmitriy Dligach; Majid Afshar
Journal:  Alcohol       Date:  2019-09-28       Impact factor: 2.405

Review 4.  Artificial Intelligence and Primary Care Research: A Scoping Review.

Authors:  Jacqueline K Kueper; Amanda L Terry; Merrick Zwarenstein; Daniel J Lizotte
Journal:  Ann Fam Med       Date:  2020-05       Impact factor: 5.166

5.  A Scalable Machine Learning Approach for Inferring Probabilistic US-LI-RADS Categorization.

Authors:  Imon Banerjee; Hailye H Choi; Terry Desser; Daniel L Rubin
Journal:  AMIA Annu Symp Proc       Date:  2018-12-05

6.  Validating a Computable Phenotype for Nephrotic Syndrome in Children and Adults Using PCORnet Data.

Authors:  Andrea L Oliverio; Dorota Marchel; Jonathan P Troost; Isabelle Ayoub; Salem Almaani; Jessica Greco; Cheryl L Tran; Michelle R Denburg; Michael Matheny; Chad Dorn; Susan F Massengill; Hailey Desmond; Debbie S Gipson; Laura H Mariani
Journal:  Kidney360       Date:  2021-09-27

Review 7.  Artificial intelligence and machine learning in precision and genomic medicine.

Authors:  Sameer Quazi
Journal:  Med Oncol       Date:  2022-06-15       Impact factor: 3.738

Review 8.  Artificial intelligence in the diagnosis of cirrhosis and portal hypertension.

Authors:  Xiaoguo Li; Ning Kang; Xiaolong Qi; Yifei Huang
Journal:  J Med Ultrason (2001)       Date:  2021-11-17       Impact factor: 1.878

9.  Diagnostic value of strand-specific miRNA-101-3p and miRNA-101-5p for hepatocellular carcinoma and a bioinformatic analysis of their possible mechanism of action.

Authors:  Xia Yang; Yu-Yan Pang; Rong-Quan He; Peng Lin; Jie-Mei Cen; Hong Yang; Jie Ma; Gang Chen
Journal:  FEBS Open Bio       Date:  2017-12-20       Impact factor: 2.693

10.  An AI Approach for Identifying Patients With Cirrhosis.

Authors:  Jihad S Obeid; Ali Khalifa; Brandon Xavier; Halim Bou-Daher; Don C Rockey
Journal:  J Clin Gastroenterol       Date:  2021-07-08       Impact factor: 3.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.